Establishment Labs Holdings (ESTA) EBITDA Margin Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 667.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667.00 |
| Dec 31, 2025 | 2,395.00 |
| Sep 30, 2025 | 2,002.00 |
| Jun 30, 2025 | -224.00 |
| Mar 31, 2025 | -2,646.00 |
| Dec 31, 2024 | -1,542.00 |
| Sep 30, 2024 | -152.00 |
| Jun 30, 2024 | -670.00 |
| Mar 31, 2024 | -1,686.00 |
| Dec 31, 2023 | -4,034.00 |
| Sep 30, 2023 | -4,325.00 |
| Jun 30, 2023 | 6,345.00 |
| Mar 31, 2023 | 1,393.00 |
| Dec 31, 2022 | -1,187.00 |
| Sep 30, 2022 | 1,085.00 |
| Jun 30, 2022 | 1,801.00 |
| Mar 31, 2022 | 2,587.00 |
| Dec 31, 2021 | 2,605.00 |
| Sep 30, 2021 | 598.00 |
| Jun 30, 2021 | 3,160.00 |
| Mar 31, 2021 | 1,253.00 |
| Dec 31, 2020 | 911.00 |
| Sep 30, 2020 | 7,014.00 |
| Jun 30, 2020 | -2,814.00 |